{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:51:30Z","timestamp":1774327890268,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Johnson & Johnson Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Polymers"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.carbpol.2025.123928","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:06:21Z","timestamp":1750359981000},"page":"123928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mass spectrometric analysis of lipid-linked oligosaccharide heterogeneity in genetically modified E. coli used for glycoconjugate bacterial vaccine production"],"prefix":"10.1016","volume":"366","author":[{"given":"Ieva","family":"Palubeckaite","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan B.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario A.T.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabel","family":"Torrente-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiep Klaas","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline","family":"Weerdenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Al Kaabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Beurret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakkumkal","family":"Anish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Nicolardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carbpol.2025.123928_bb0005","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1021\/cr3003714","article-title":"High-sensitivity analytical approaches for the structural characterization of glycoproteins","volume":"113","author":"Alley","year":"2013","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.carbpol.2025.123928_bb0010","doi-asserted-by":"crossref","first-page":"35709","DOI":"10.1074\/jbc.M404738200","article-title":"Nonreducing terminal modifications determine the chain length of polymannose O antigens of Escherichia coli and couple chain termination to polymer export via an ATP-binding cassette transporter*","volume":"279","author":"Clarke","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0015","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1515\/hsz-2012-0135","article-title":"The GlycanBuilder and GlycoWorkbench glycoinformatics tools: Updates and new developments","volume":"393","author":"Damerell","year":"2012","journal-title":"Biological Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122327","article-title":"Comprehensive characterization of bacterial glycoconjugate vaccines by liquid chromatography - mass spectrometry","volume":"341","author":"Di Marco","year":"2024","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2025.123928_bb0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41598-017-00703-w","article-title":"Ultra-high mass resolution MALDI imaging mass spectrometry of proteins and metabolites in a mouse model of glioblastoma","volume":"7","author":"Dilillo","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.carbpol.2025.123928_bb0030","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2016.06.067","article-title":"Immunogenicity and safety of a tetravalent E. Coli O-antigen bioconjugate vaccine in animal models","volume":"34","author":"van den Dobbelsteen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.carbpol.2025.123928_bb0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01049915","article-title":"A systematic nomenclature for carbohydrate fragmentations in FAB-MS\/MS spectra of glycoconjugates","volume":"5","author":"Domon","year":"1988","journal-title":"Glycoconjugate Journal"},{"key":"10.1016\/j.carbpol.2025.123928_bb0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/14760584.2020.1775077","article-title":"Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production","volume":"19","author":"Dow","year":"2020","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.carbpol.2025.123928_bb0045","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1073\/pnas.0500044102","article-title":"Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in <i>Escherichia coli<\/i>","volume":"102","author":"Feldman","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.carbpol.2025.123928_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad417","article-title":"Safety, Reactogenicity, immunogenicity, and dose selection of 10-valent Extraintestinal pathogenic Escherichia coli bioconjugate vaccine (VAC52416) in adults aged 60\u201385 years in a randomized, multicenter, interventional, first-in-human, phase 1\/2a study","volume":"10","author":"Fierro","year":"2023","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.carbpol.2025.123928_bb0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fmicb.2016.00644","article-title":"Advances in molecular serotyping and subtyping of Escherichia coli","volume":"7","author":"Fratamico","year":"2016","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0060","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2666-5247(22)00303-2","article-title":"The role of bacterial vaccines in the fight against antimicrobial resistance: An analysis of the preclinical and clinical development pipeline","volume":"4","author":"Frost","year":"2023","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.carbpol.2025.123928_bb0065","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.1128\/AEM.71.12.7995-8001.2005","article-title":"Molecular analysis of the O-antigen gene cluster of Escherichia coli O86:B7 and characterization of the chain length determinant gene (wzz)","volume":"71","author":"Guo","year":"2005","journal-title":"Applied and Environmental Microbiology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mas.21873","article-title":"Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption\/ionization mass spectrometry: An update for 2021-2022","volume":"44","author":"Harvey","year":"2025","journal-title":"Mass Spectrometry Reviews"},{"key":"10.1016\/j.carbpol.2025.123928_bb0075","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s12879-023-08479-3","article-title":"Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States","volume":"23","author":"Hernandez-Pastor","year":"2023","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.carbpol.2025.123928_bb0080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(17)30108-1","article-title":"Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: A randomised, single-blind, placebo-controlled phase 1b trial","volume":"17","author":"Huttner","year":"2017","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.carbpol.2025.123928_bb0085","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the global burden of disease study 2019","volume":"400","author":"Ikuta","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.carbpol.2025.123928_bb0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0008-6215(00)90084-3","article-title":"Structural studies of the O-specific side-chains of the Escherichia coli O2 lipopolysaccharide","volume":"161","author":"Jansson","year":"1987","journal-title":"Carbohydrate Research"},{"key":"10.1016\/j.carbpol.2025.123928_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrmicro818","article-title":"Pathogenic Escherichia coli","volume":"2","author":"Kaper","year":"2004","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0100","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1128\/JB.182.24.7029-7034.2000","article-title":"Regulatable arabinose-inducible gene expression system with consistent control in all cells of a culture","volume":"182","author":"Khlebnikov","year":"2000","journal-title":"Journal of Bacteriology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0105","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1021\/acs.analchem.3c05252","article-title":"Imaging mass spectrometry of isotopically resolved intact proteins on a trapped ion-mobility quadrupole time-of-flight mass spectrometer","volume":"96","author":"Klein","year":"2024","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10719-021-09985-9","article-title":"The development and characterization of an E. Coli O25B bioconjugate vaccine","volume":"38","author":"Kowarik","year":"2021","journal-title":"Glycoconjugate Journal"},{"key":"10.1016\/j.carbpol.2025.123928_bb0115","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/femsre\/fuz028","article-title":"Structure and genetics of Escherichia coli O antigens","volume":"44","author":"Liu","year":"2019","journal-title":"FEMS Microbiology Reviews"},{"key":"10.1016\/j.carbpol.2025.123928_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13756-021-00999-4","article-title":"Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: A multinational population-based cohort study","volume":"10","author":"MacKinnon","year":"2021","journal-title":"Antimicrobial Resistance & Infection Control"},{"key":"10.1016\/j.carbpol.2025.123928_bb0125","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00135-18","article-title":"Global Extraintestinal pathogenic Escherichia coli (ExPEC) lineages","volume":"32","author":"Manges","year":"2019","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.carbpol.2025.123928_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-7012(99)00109-8","article-title":"Resolution of high-molecular-weight components in lipopolysaccharides of Escherichia coli, Morganella morganii, Citrobacter freundii and Citrobacter diversus strains with sodium dodecyl sulfate polyacrylamide gels","volume":"39","author":"del Mar Tav\u00edo","year":"2000","journal-title":"Journal of Microbiological Methods"},{"key":"10.1016\/j.carbpol.2025.123928_bb0135","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: A systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"The Lancet"},{"key":"10.1016\/j.carbpol.2025.123928_bb0140","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1021\/ac504708y","article-title":"Top-down MALDI-in-source decay-FTICR mass spectrometry of isotopically resolved proteins","volume":"87","author":"Nicolardi","year":"2015","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0145","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1021\/acs.analchem.1c00239","article-title":"Analysis of synthetic monodisperse polysaccharides by wide mass range ultrahigh-resolution MALDI mass spectrometry","volume":"93","author":"Nicolardi","year":"2021","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0150","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1021\/acs.analchem.1c04690","article-title":"Glycan and protein analysis of Glycoengineered Bacterial E. Coli vaccines by MALDI-in-source decay FT-ICR mass spectrometry","volume":"94","author":"Nicolardi","year":"2022","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1139\/o86-004","article-title":"Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli 0:157:H7","volume":"64","author":"Perry","year":"1986","journal-title":"Biochemistry and Cell Biology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiv429","article-title":"Extraintestinal pathogenic Escherichia coli, a common human pathogen: Challenges for vaccine development and Progress in the field","volume":"213","author":"Poolman","year":"2015","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.carbpol.2025.123928_bb0165","doi-asserted-by":"crossref","first-page":"15832","DOI":"10.1021\/acs.analchem.1c01043","article-title":"Nanoflow LC\u2013MS method allowing in-depth characterization of natural heterogeneity of complex bacterial lipopolysaccharides","volume":"93","author":"Pupo","year":"2021","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0170","doi-asserted-by":"crossref","first-page":"2359691","DOI":"10.1080\/19490976.2024.2359691","article-title":"Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): Progress and challenges","volume":"16","author":"Qiu","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.carbpol.2025.123928_bb0175","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0180","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0966-842X(00)88983-0","article-title":"Role of O-antigen variation in the immune response","volume":"3","author":"Reeves","year":"1995","journal-title":"Trends in Microbiology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0185","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1021\/ac800079r","article-title":"Affinity-capture tandem mass spectrometric characterization of Polyprenyl-linked oligosaccharides: Tool to study protein N-glycosylation pathways","volume":"80","author":"Reid","year":"2008","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0190","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1021\/ac9013622","article-title":"Analysis of bacterial lipid-linked oligosaccharide intermediates using porous graphitic carbon liquid chromatography-electrospray ionization mass spectrometry: Heterogeneity in the Polyisoprenyl Carrier revealed","volume":"81","author":"Reid","year":"2009","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-60761-454-8_13","article-title":"Characterization of lipid-linked oligosaccharides by mass spectrometry","volume":"600","author":"Reid","year":"2010","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1351\/PAC-REC-08-05-02","article-title":"Dispersity in polymer science (IUPAC recommendations 2009)","volume":"81","author":"Stepto","year":"2009","journal-title":"Pure and Applied Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0205","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/CVI.00685-13","article-title":"Diagnostic potential of monoclonal antibodies specific to the unique O-antigen of multidrug-resistant epidemic Escherichia coli clone ST131-O25b:H4","volume":"21","author":"Szij\u00e1rt\u00f3","year":"2014","journal-title":"Clinical and Vaccine Immunology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0210","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AEM.02452-06","article-title":"Simple method for Repurification of endotoxins for biological use","volume":"73","author":"Tirsoaga","year":"2007","journal-title":"Applied and Environmental Microbiology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0215","article-title":"Glycan-selective MALDI in-source decay analysis of intact glycoproteins","volume":"2","author":"Urakami","year":"2022","journal-title":"Analysis & Sensing"},{"key":"10.1016\/j.carbpol.2025.123928_bb0220","doi-asserted-by":"crossref","first-page":"12719","DOI":"10.1038\/s41598-024-62729-1","article-title":"MALDI glycotyping of O-antigens from a single colony of gram-negative bacteria","volume":"14","author":"Urakami","year":"2024","journal-title":"Scientific Reports"},{"key":"10.1016\/j.carbpol.2025.123928_bb0225","article-title":"MALDI O-antigen glycotyping of Y. pseudotuberculosis using DAN\/DHB\/K matrix. BBA","volume":"7","author":"Urakami","year":"2025","journal-title":"Advances"},{"key":"10.1016\/j.carbpol.2025.123928_bb0230","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.3390\/ijms242015040","article-title":"Structural and genetic identification of the O-antigen from an Escherichia coli isolate, SD2019180, representing a novel serogroup","volume":"24","author":"Wang","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.carbpol.2025.123928_bb0235","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/infdis\/jiae097","article-title":"Heptavalent O-antigen bioconjugate vaccine exhibiting differential functional antibody responses against diverse Klebsiella pneumoniae isolates","volume":"230","author":"Wantuch","year":"2024","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.carbpol.2025.123928_bb0240","doi-asserted-by":"crossref","first-page":"e1236","DOI":"10.1093\/cid\/ciac421","article-title":"Global distribution of O serotypes and antibiotic resistance in Extraintestinal pathogenic Escherichia coli collected from the blood of patients with bacteremia across multiple surveillance studies","volume":"76","author":"Weerdenburg","year":"2022","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.carbpol.2025.123928_bb0245","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10719-012-9451-9","article-title":"Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component","volume":"30","author":"Wetter","year":"2013","journal-title":"Glycoconjugate Journal"},{"key":"10.1016\/j.carbpol.2025.123928_bb0250","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1074\/jbc.REV120.009402","article-title":"Lipopolysaccharide O-antigens\u2014Bacterial glycans made to measure","volume":"295","author":"Whitfield","year":"2020","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.carbpol.2025.123928_bb0255","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nchembio.351","article-title":"In vitro bacterial polysaccharide biosynthesis: Defining the functions of Wzy and Wzz","volume":"6","author":"Woodward","year":"2010","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.carbpol.2025.123928_bb0260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.carres.2018.05.001","article-title":"Structural and genetic relatedness of the O-antigens of Escherichia coli O50 and O2","volume":"464","author":"Yang","year":"2018","journal-title":"Carbohydrate Research"}],"container-title":["Carbohydrate Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861725007118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861725007118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:33:01Z","timestamp":1762245181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0144861725007118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":52,"alternative-id":["S0144861725007118"],"URL":"https:\/\/doi.org\/10.1016\/j.carbpol.2025.123928","relation":{},"ISSN":["0144-8617"],"issn-type":[{"value":"0144-8617","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mass spectrometric analysis of lipid-linked oligosaccharide heterogeneity in genetically modified E. coli used for glycoconjugate bacterial vaccine production","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Polymers","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carbpol.2025.123928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"123928"}}